These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25450172)

  • 1. Extension of the free energy workflow FEW towards implicit solvent/implicit membrane MM-PBSA calculations.
    Homeyer N; Gohlke H
    Biochim Biophys Acta; 2015 May; 1850(5):972-982. PubMed ID: 25450172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FEW: a workflow tool for free energy calculations of ligand binding.
    Homeyer N; Gohlke H
    J Comput Chem; 2013 Apr; 34(11):965-73. PubMed ID: 23288722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free energy calculations on the two drug binding sites in the M2 proton channel.
    Gu RX; Liu LA; Wei DQ; Du JG; Liu L; Liu H
    J Am Chem Soc; 2011 Jul; 133(28):10817-25. PubMed ID: 21711026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density functional theory calculations on entire proteins for free energies of binding: application to a model polar binding site.
    Fox SJ; Dziedzic J; Fox T; Tautermann CS; Skylaris CK
    Proteins; 2014 Dec; 82(12):3335-46. PubMed ID: 25212393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational and experimental analysis of drug binding to the Influenza M2 channel.
    Alhadeff R; Assa D; Astrahan P; Krugliak M; Arkin IT
    Biochim Biophys Acta; 2014 Apr; 1838(4):1068-73. PubMed ID: 24016551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach.
    Klimochkin YN; Shiryaev VA; Petrov PV; Radchenko EV; Palyulin VA; Zefirov NS
    Curr Comput Aided Drug Des; 2016; 12(2):154-64. PubMed ID: 27146707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics.
    Watkins LC; DeGrado WF; Voth GA
    J Am Chem Soc; 2020 Oct; 142(41):17425-17433. PubMed ID: 32933245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting free energy surfaces in implicit and explicit solvent: an efficient method to compute conformational and solvation free energies.
    Deng N; Zhang BW; Levy RM
    J Chem Theory Comput; 2015 Jun; 11(6):2868-78. PubMed ID: 26236174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in implicit models of water solvent to compute conformational free energy and molecular dynamics of proteins at constant pH.
    Vorobjev YN
    Adv Protein Chem Struct Biol; 2011; 85():281-322. PubMed ID: 21920327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing the robustness of the MM/PBSA free energy calculation method: application to DNA conformational transitions.
    Brice AR; Dominy BN
    J Comput Chem; 2011 May; 32(7):1431-40. PubMed ID: 21284003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-bonded water molecules in the M2 channel of the influenza A virus guide the binding preferences of ammonium-based inhibitors.
    Gianti E; Carnevale V; DeGrado WF; Klein ML; Fiorin G
    J Phys Chem B; 2015 Jan; 119(3):1173-83. PubMed ID: 25353315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database.
    Lin CH; Chang TT; Sun MF; Chen HY; Tsai FJ; Chang KL; Fisher M; Chen CY
    J Biomol Struct Dyn; 2011 Feb; 28(4):471-82. PubMed ID: 21142218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the SAMPL5 host-guest challenge: Are we doing better?
    Yin J; Henriksen NM; Slochower DR; Shirts MR; Chiu MW; Mobley DL; Gilson MK
    J Comput Aided Mol Des; 2017 Jan; 31(1):1-19. PubMed ID: 27658802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of MM/GBSA calculations based on explicit and implicit solvent simulations.
    Godschalk F; Genheden S; Söderhjelm P; Ryde U
    Phys Chem Chem Phys; 2013 May; 15(20):7731-9. PubMed ID: 23595060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.